ASX Share rice
Mon 17 May 2021 - 03:38:am (Sydney)

BD1 Share Price

BARD1 LIFE SCIENCES LIMITEDBD1Health Care Equipment & Services

BD1 Company Information

Name:

BARD1 Life Sciences Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Health Care Providers & Services

GIC Sub Industry:

Health Care Services

Address:

23 Normanby Road South Perth WA Australia 3168

Phone:

61 3 9548 7586

Chief Exec. Officer:

Dr. Leearne Maree Hinch BSc., B.V.M.S., M.R.C.V.S., M.B.A.

Managing Director:

Mr. Peter Lynton Gunzburg B Comm, ASIA

CFO & Joint Company Sec.:

Mr. Tony Di Pietro AGIA, C.A., M.A.I.C.D., B.Com, CPA

Chief Operating Officer:

Mr. Carl S. Stubbings

Chief Scientific Officer:

Dr. Peter William French M.B.A., B.Sc., M.Sc., Ph.D., MBA, FRSM

Joint Company Sec.:

Ms. Pauline Anne Collinson

Company Overview:

BARD1 Life Sciences Limited engages in the research and development of non-invasive diagnostic tests for early detection of cancer in Australia. The company offers hTERT test for diagnosis of bladder cancer, with the development-stage BARD1 autoantibody test for early detection of ovarian, breast and lung cancers; hTERT ICC test, an antibody-based immunocytochemistry stain that detects a component of telomerase; EXO-NET, a technology to capture and isolation of exosomes from any liquid biopsy sample; and BARD1 autoantibodies test to evaluate autoantibody panels and algorithms for detection of ovarian, breast and lung cancers. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in South Perth, Australia.

BD1 Share Price Information

Shares Issued:

80.06M

Market Capitalisation:

$196.94M

Revenue (TTM):

$612.25K

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.001

Operating Margin (TTM):

$-6.61

Return On Assets (TTM):

$-0.10

Return On Equity (TTM):

$-0.21

Quarterly Revenue Growth (YOY):

-0.17

Gross Profit(TTM):

$-220,796

Diluted Earnings Per Share (TTM):

$-0.083

BD1 CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$368.40K

Net Income:

$-3,253,553

Total Cash From Operating Activities:

$-2,536,577

Change To Account Receivables:

$39.90K

Sale Purchase Of Stock:

$2.49M

Capital Expenditures:

$0

BD1 Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,253,550

Net Income:

$-3,253,550

Operating Income:

$-3,328,690

Total Revenue:

$98.39K

BD1 Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$899.12K

Total Stockholder Equity:

$6.48M

Total Assets:

$7.37M

Common Stock:

$19.29M

Retained Earnings:

$-12,828,179

Other Liabilities:

$23.19K

Cash:

$7.33M

Total Current Liabilities:

$875.93K

Net Tangible Assets:

$6.48M

Total Current Assets:

$7.37M

Net Receivables:

$21.38K

Short-Term Investments:

$0

Accounts Payable:

$798.86K

Short-Term Investments:

$0

Non Current Liabilities Total:

$23.19K

BD1 Share Price History

BD1 News

11 May, 2021
If you want to know who really controls BARD1 Life Sciences Limited ( ASX:BD1 ), then you'll have to look at the makeup...
12 Nov, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
16 May, 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...